In HCC1806 breast cancer cells, resveratrol downregulates the DNMT1, DNMT3a, DNMT3b, and negatively regulated hTERT with the inhibition of SIRT followed by the inhibition of breast cancer cell growth [112]. Here, DNMT1 is linked to breast cancer.